197A — TAUNS Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Yuho	Tanshin
Standards:	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	6,347	1,244	9,425	9,267
Net Total Accounts Receivable
Net Total Receivables	942	3,481	2,723	248
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,036	9,457	16,916	15,477
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,683	4,402	7,905	12,279
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20,268	18,332	29,261	36,515
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,937	6,518	10,474	9,530
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	12,912	9,842	15,595	19,098
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,356	8,490	13,667	17,418
Total Liabilities & Shareholders' Equity	20,268	18,332	29,261	36,515
Total Common Shares Outstanding